Literature DB >> 3926825

A method to determine significant levels of immunoglobulin G to Aspergillus fumigatus antigens in an ELISA system and a comparison with counterimmunoelectrophoresis and double diffusion techniques.

V M Hearn, G C Donaldson, M J Healy.   

Abstract

A method is described which assesses results obtained from an ELISA system for the determination of human serum levels of IgG class antibodies to Aspergillus fumigatus. The method is used to discriminate positive from negative samples, and significant antibody activity may be reported to the clinician, relative to a reference positive control serum monitored simultaneously under the same test conditions. Antibody content is expressed as the absorbance of a certain dilution of serum. Duplicate samples were analysed at a single serum dilution and their absorbtion values obtained from a semi-automated ELISA microplate reader. These were entered into a computer programmed to convert the data into units on a logarithmic scale. In parallel experiments, ELISA results were compared with those obtained by the techniques of counterimmunoelectrophoresis and double diffusion which measure precipitating antibody of all classes. A relatively good degree of correlation between tests was found only among sera with a high level of antibody.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926825     DOI: 10.1080/01971528508063026

Source DB:  PubMed          Journal:  J Immunoassay        ISSN: 0197-1522


  3 in total

Review 1.  Serological techniques for diagnosis of fungal infection.

Authors:  L de Repentigny
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

2.  Aspergillus Fumigatus antigen detection in sera from patients at risk for invasive aspergillosis.

Authors:  B F Chumpitazi; C Pinel; B Lebeau; P Ambroise-Thomas; R Grillot
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Characterization of a second major antigen Ag 13 (antigen C) of Aspergillus fumigatus and investigation of its immunological reactivity.

Authors:  C Harvey; J L Longbottom
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.